James A. Bianco, President and CEO at CTI BIOPHARMA CORP (CTIC), sold 260,000 shares at $1.35 ($351K) on 2015-10-30, disclosed to the SEC on 2015-10-30.
Scheduled sale ($351k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CTIC | SELL | 2016-04-29 | $5K | — | Filing → |
| CTIC | SELL | 2016-03-30 | $5K | — | Filing → |
| CTIC | SELL | 2016-03-23 | $350K | — | Filing → |